EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

BMJ Open Gastroenterology

ISSN 2054-4774 · BMJ

Neueste Artikel

  1. Evaluating the non-inferiority of HIPEC with mitomycin C 10 mg/m 2 for 60 min versus HIPEC with mitomycin C 35 mg/m 2 for 90 min in the treatment of pseudomyxoma peritonei from perforated epithelial mucinous tumours of the appendix (HIPEC-PMP): protocol for a single-blinded, randomised controlled trial

    Sean Ewings, Sophia Stanford, Chris Wignall, Karen Martin, Pavel Mozgunov, Gianmarco Caruso, Louise Holmes, Paul Smith, David Scott, Gareth Griffiths, Alexios Tzivanakis, Sanjeev Dayal, Vasanth Mark Samuel, Gui Han Lee, Brendan Moran, Faheez Mohamed, Tom Cecil

    Erschienen: 2026-11DOI: 10.1136/bmjgast-2025-002187

  2. Open-IBD: protocol for a longitudinal multi-omics inception cohort in inflammatory bowel disease

    Robert J Mulligan, Cristina Cotobal Martin, Dean M Allerton, Michelle Strickland, Irena Bibby, Laura Fachal, Hannah Watson, Georgina Bates, Lauren C Beck, Tariq Ahmad, Jonathan Blackwell, Robin J Dart, Chaonan Dong, Mary Doona, Jennifer Doyle, Tony Fouweather, Elliot Gemmell, Richard Hall, Peter M Irving, Katherine Jacques, Nicholas A Kennedy, Andrew Thomas King, James C Lee, Charlie W Lees, Robert D Lees, James O Lindsay, Andrea C Masi, Christopher Palmer-Jones, Gareth C Parkes, Miles Parkes, Kamal V Patel, Sebastian Povlsen, Nicholas Powell, Jonathan Prichard, Tim Raine, Christopher Roberts, Emmanuel Samuel, R Ally Speight, Sreedhar Subramanian, Paola Reis

    Erschienen: 2026-11DOI: 10.1136/bmjgast-2026-002501

  3. Safety and effectiveness of the Colovac anastomosis protection device compared with diverting ileostomy after low anterior resection: protocol for an international, multicentre, prospective, non-randomised comparative study (SAFE-3)

    Clément Pastier, Patricia Sylla, Sang W Lee, Antonino Spinelli, Niels Komen, John Marks, Joseph Martz, Rebecca Rhee, Justin Maykel, Jorge Marcet, Quentin Denost, Karen Zaghiyan, Jennifer S Davids, Nivedh Paluvoi, David Hiller, Elisabeth C McLemore, Leon Maggiori, Andre D’hoore, Mehraneh D Jafari, Vitaliy Poylin, Christopher Jerome Buzas, Jean-Jaques Tuech, Jérémie H Lefèvre

    Erschienen: 2026-06DOI: 10.1136/bmjgast-2025-002235

  4. Effectiveness and safety of mirikizumab in ulcerative colitis: real-world data from the Latium Net

    Marco Murgiano, Paola Balestrieri, Emma Calabrese, Gionata Fiorino, Stefano Festa, Daniela Pugliese, Federica Di Vincenzo, Pierluigi Puca, Simone Parello, Valeria Vespasiano, Alice Colella, Irene Marafini, Francesca Profeta, Elisa Foscarini, Alfredo Papa, Loris Riccardo Lopetuso, Giovanni Monteleone, Michele Cicala, Antonio Gasbarrini, Lucrezia Laterza, Franco Scaldaferri

    Erschienen: 2026-05DOI: 10.1136/bmjgast-2025-002232

  5. Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trial

    Vipul Jairath, Sudheer K Vuyyuru, Guangyong Zou, Christopher Ma, Blue Neustifter, Christian Agboton, Itzel Romo Bautista, Mariangela Allocca, Yoon-Kyo An, Jakob Begun, Robert V Bryant, Silvio Danese, Marla Dubinsky, Brian G Feagan, Marcelo Freire, Kerri L Novak, Remo Panaccione, Aviv Pudipeddi, David T Rubin, Bruce E Sands, Miles P Sparrow, Stuart A Taylor, Krisztina B Gecse, Rune Wilkens, Christian Maaser

    Erschienen: 2026-02DOI: 10.1136/bmjgast-2025-002088

  6. Artificial intelligence-assisted versus conventional reading in pan-intestinal capsule endoscopy for suspected mid-lower gastrointestinal bleeding: a retrospective analysis of a prospective cohort

    Bruno Rosa, Miguel José Mascarenhas Saraiva, João Afonso, Tiago Cúrdia Gonçalves, Francisco Mendes, Maria João Moreira, Miguel Martins, Francisca Dias de Castro, Tiago Ribeiro, Pedro Cardoso, Maria João Almeida, Joana Mota, João Ferreira, Guilherme Macedo, José Cotter

    Erschienen: 2025-10DOI: 10.1136/bmjgast-2025-001906

  7. Effectiveness and safety of upadacitinib in a real-world cohort of patients with Crohn’s disease in the UK: a multicentre retrospective cohort study

    Yaa Danso, Chandni Radia, Alex Elford, Jie Han Yeo, Thomas Morris, Chirag Patel, Kimberley Butler, Sonia Kalyanji, Katie Yeung, Chaonan Dong, Karishma Sethi-Arora, Alice Hewitt, Lushen Pillay, Susan Ritchie, Mohammed Allah-Ditta, Lucy Hicks, Phil Harvey, Fiona Rees, Emma Johnston, Ruth Rudling, Charlie Lees, Jennifer Toft, Sara Mccartney, Xinyi Choon, Richard C G Pollok, Dania Al-Zarrad, Melissa Hale, Christopher Andrew Lamb, R Alexander Speight, Jimmy Limdi, Hannah Trodden-Mittnacht, Konstantina Rosiou, Tim Raine, Anjan Dhar, Puneet Chhabra, Nick N Burr, Paul Harrow, Kamal V Patel, Mark Samaan, Polychronis Pavlidis

    Erschienen: 2025-10DOI: 10.1136/bmjgast-2025-001916

  8. Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial

    Siddharth Singh, Jasmine D Nguyen, David I Fudman, Mark E Gerich, Samir A Shah, David Hudesman, Ryan A McConnell, Dana J Lukin, Ann D Flynn, Caroline Hwang, Brandon Sprung, Jill K J Gaidos, Mark C Mattar, David T Rubin, Jana G Hashash, Mark Metwally, Tauseef Ali, Christopher Ma, Frank Hoentjen, Neeraj Narula, Talat Bessissow, Greg Rosenfeld, Jeffrey D McCurdy, Ashwin N Ananthakrishnan, Raymond K Cross, Jorge R Rodriguez Gaytan, Emily-Sophinie Gurrola, Sagar Patel, Corey A Siegel, Gil Y Melmed, S Alandra Weaver, Sydney Power, Guangyong Zou, Vipul Jairath, Jason K Hou

    Erschienen: 2025-03DOI: 10.1136/bmjgast-2024-001615

Jahrgänge

2026 · 462025 · 992024 · 802023 · 642022 · 752021 · 962020 · 832019 · 612018 · 342017 · 452016 · 432015 · 282014 · 9

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.